Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131n\u0131n koordinasyonunda T\u00fcrk K\u0131z\u0131lay\u0131n\u0131n y\u00fcr\u00fct\u00fcc\u00fcl\u00fc\u011f\u00fcnde, k\u00fcresel bir sa\u011fl\u0131k sorunu haline gelen yeni tip koronavir\u00fcs (Kovid-19) tedavisinde kullan\u0131laca\u011f\u0131 duyurulan “imm\u00fcn plazma” tedavisi gelecek hafta devreye al\u0131nacak.<\/p>\n
\u0130lk olarak \u00c7in’in Vuhan kentinde ge\u00e7en y\u0131l aral\u0131k ay\u0131nda ortaya \u00e7\u0131kan, zamanla farkl\u0131 \u00fclke ve b\u00f6lgelere s\u0131\u00e7rayarak binlerce ki\u015fiye bula\u015fan koronavir\u00fcs salg\u0131n\u0131n\u0131 sona erdirmesi umut edilen ila\u00e7 ve a\u015f\u0131 geli\u015ftirme \u00e7al\u0131\u015fmalar\u0131 baz\u0131 \u00fclkelerde devam ediyor.<\/p>\n
Kovid-19 ile m\u00fccadele kapsam\u0131nda T\u00fcrkiye’de de hastal\u0131\u011f\u0131n tedavisinde kullan\u0131lacak yeni y\u00f6ntemler \u00fczerindeki \u00e7al\u0131\u015fmalar h\u0131z kazand\u0131.<\/p>\n
D\u00fcnya Sa\u011fl\u0131k \u00d6rg\u00fct\u00fc’n\u00fcn, geli\u015fmekte olan Kovid-19 salg\u0131n\u0131na kar\u015f\u0131 kan mevzuat\u0131 i\u00e7in yay\u0131nlad\u0131\u011f\u0131 ara durum bildirgesi ile pandemi s\u0131ras\u0131nda imm\u00fcn plazma tedavisinin en \u00e7ok tavsiye edilen potansiyel tedavilerden biri oldu\u011funu, yetkili otoritelerin imm\u00fcn plazma veya serumun toplanmas\u0131 i\u00e7in uygun d\u00fczenleyici ko\u015fullar\u0131 olu\u015fturarak bu alanda ilerlemeleri gerekti\u011fini a\u00e7\u0131klamas\u0131n\u0131n\u0131 ard\u0131ndan 24 Mart tarihinde de ABD G\u0131da ve \u0130la\u00e7 \u0130daresinin “Kovid-19 Konvansiyonel Plazma Ara\u015ft\u0131rmas\u0131 – Acil Durum” bildirgesi ile ayn\u0131 konuda bir tavsiye karar\u0131 yay\u0131nlad\u0131.<\/p>\n
Bu kapsamda Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131nca, T\u00fcrkiye’de de etkisini g\u00f6stermeye ba\u015flayan Kovid-19 pandemisinde, ihtiya\u00e7 duyan hastalarda kullan\u0131lmak \u00fczere imm\u00fcn plazman\u0131n temini ve kullan\u0131m\u0131 konusunda \u00e7al\u0131\u015fma ba\u015flat\u0131ld\u0131.<\/p>\n
Bu \u00e7er\u00e7evede T\u00fcrk K\u0131z\u0131lay\u0131 B\u00f6lge Kan Merkezleri ile S\u00fcreli B\u00f6lge Kan Merkezleri b\u00fcnyesinde Bakanl\u0131k\u00e7a ruhsatland\u0131r\u0131lm\u0131\u015f aferez merkezi bulunan kamu, \u00f6zel ve vak\u0131f \u00fcniversite hastaneleri, e\u011fitim ve ara\u015ft\u0131rma hastaneleri ile kamu yarar\u0131 g\u00f6zeten vak\u0131f hastanelerinin Kovid-19 enfeksiyonu ge\u00e7irmi\u015f olan ba\u011f\u0131\u015f\u00e7\u0131dan tan\u0131mlanan kriterler \u00e7er\u00e7evesinde ve bu hastanelerin transf\u00fczyon merkezleri sorumlulu\u011funda imm\u00fcn plazma elde edilmesine y\u00f6nelik faaliyetlerin y\u00fcr\u00fctebilece\u011fi bildirildi.<\/p>\n
Ayr\u0131ca T\u00fcrk K\u0131z\u0131lay\u0131 Genel Ba\u015fkan\u0131 Kerem K\u0131n\u0131k da d\u00fcn Kuzey Marmara B\u00f6lge Kan Merkezi laboratuvar\u0131nda online d\u00fczenledi\u011fi bas\u0131n toplant\u0131s\u0131nda, “imm\u00fcn plazma” tedavisine ili\u015fkin bilgi vererek, ba\u011f\u0131\u015f\u00e7\u0131lardan plazma al\u0131mlar\u0131n\u0131n gelecek hafta ba\u015flayaca\u011f\u0131n\u0131 duyurdu.<\/p>\n
\u0130mm\u00fcn plazma tedavisinde koronavir\u00fcs (Kovid-19) tan\u0131s\u0131 konan ve tedavi s\u00fcrecinin ard\u0131ndan iyile\u015fen hastalardan al\u0131nan ve T\u00fcrk K\u0131z\u0131lay\u0131 taraf\u0131ndan toplanan kan plazmalar\u0131n\u0131n a\u011f\u0131r durumdaki vakalar\u0131n tedavisinde kullan\u0131lmas\u0131 ama\u00e7lan\u0131yor. Bu sayede kan plazmas\u0131 ile kritik durumdaki hastalar\u0131n tedavi edilmesi hedefleniyor.<\/p>\n
Plazmada yer alan “imm\u00fcnglobulin” denilen antikorlar, yo\u011fun bak\u0131ma al\u0131nm\u0131\u015f, solunum s\u0131k\u0131nt\u0131s\u0131na girmi\u015f, durumu k\u00f6t\u00fcye giden ve riski y\u00fckselmi\u015f hastalar\u0131 tedavi edici \u00f6zellik ta\u015f\u0131yor.<\/p>\n
Plazma ba\u011f\u0131\u015f\u0131 i\u00e7in “Kovid-19 tan\u0131s\u0131 al\u0131nd\u0131ktan sonra uygulanan tedavi ile iyile\u015fen ve taburcu olan 18-65 ya\u015f aral\u0131\u011f\u0131nda olup kan verme \u00f6zelliklerini ta\u015f\u0131yan, kan vermeye engel te\u015fkil eden hepatit, HIV, spilis gibi hastal\u0131klar\u0131 bulunmayan” ki\u015fi \u015fartlar\u0131 aran\u0131rken s\u00fcre\u00e7 \u015fu \u015fekilde i\u015fleyecek:<\/p>\n
1- Ki\u015finin koronavir\u00fcsle enfekte oldu\u011fu yap\u0131lan testlerle belirlenecek.<\/p>\n
2- Hastaya tedavi s\u00fcre\u00e7leri uygulanacak.<\/p>\n
3- Tedavi s\u00fcre\u00e7leri sonras\u0131 iyile\u015fen ki\u015fi kan ba\u011f\u0131\u015f\u0131ndan \u00f6nce 14 g\u00fcn bekleme s\u00fcrecine girecek.<\/p>\n
4- Plazma ba\u011f\u0131\u015f\u0131ndan \u00f6nce tekrar test yap\u0131lacak.<\/p>\n
5- Negatif sonucu g\u00f6steren raporla ba\u011f\u0131\u015f\u00e7\u0131 K\u0131z\u0131lay’\u0131n aferez ba\u011f\u0131\u015f noktalar\u0131na gidecek.<\/p>\n
6- Ba\u011f\u0131\u015f\u00e7\u0131n\u0131n kan vermesinde sak\u0131nca olup olmad\u0131\u011f\u0131 tespiti yap\u0131lacak ve beyan\u0131 ile onam formu al\u0131nacak.<\/p>\n
7- Kan ba\u011f\u0131\u015f\u00e7\u0131s\u0131n\u0131n kan\u0131nda bulunan ve hastan\u0131n ihtiyac\u0131 olan plazma, aferez cihaz\u0131nda ayr\u0131\u015ft\u0131r\u0131lacak ve di\u011fer bile\u015fenler kan ba\u011f\u0131\u015f\u00e7\u0131s\u0131na geri verilecek.<\/p>\n
8- Al\u0131nan plazma i\u00e7in standart testler uygulanacak.<\/p>\n
9- Testleri tamamlanan plazma, tedavi bekleyen uygun hastalar i\u00e7in ilgili hastanelere ula\u015ft\u0131r\u0131lacak.<\/p>\n
T\u00fcrk K\u0131z\u0131lay\u0131 kan ba\u011f\u0131\u015f\u0131 merkezlerinde yap\u0131lan bu i\u015flem, kan ba\u011f\u0131\u015f\u00e7\u0131s\u0131n\u0131n aferez cihaz\u0131na ba\u011flanarak, kan bile\u015feni elde edilmesini sa\u011flayan bir kan ba\u011f\u0131\u015f\u0131 t\u00fcr\u00fcd\u00fcr. Cihaz, ba\u011f\u0131\u015f\u00e7\u0131n\u0131n kan\u0131n\u0131 k\u00fc\u00e7\u00fck miktarlarda alarak ihtiya\u00e7 olan bile\u015feni ay\u0131r\u0131r ve kan\u0131n ilgili bile\u015feninin d\u0131\u015f\u0131nda kalan taraf\u0131n\u0131 ba\u011f\u0131\u015f\u00e7\u0131ya geri verir. \u0130\u015flem 45 ila 60 dakika s\u00fcrer.<\/p>\n
Kovid-19’a yakalanm\u0131\u015f ve iyile\u015fmi\u015f bireylerin ba\u011f\u0131\u015f yapmas\u0131 durumunda uygulanacak ko\u015fullar:<\/p>\n
1- Plazma ba\u011f\u0131\u015f\u0131 yapacak ki\u015filerin, enfeksiyonu ge\u00e7irmi\u015f oldu\u011funa dair laboratuvar test sonucu gereklidir.<\/p>\n
2- Ba\u011f\u0131\u015ftan 14 g\u00fcn \u00f6ncesinde bu ki\u015filerin klinik semptomlar\u0131 tamam\u0131yla ortadan kalkm\u0131\u015f olmal\u0131d\u0131r.<\/p>\n
3- Bir ya da daha fazla kez olmak kayd\u0131yla nazofarengeal s\u00fcr\u00fcnt\u00fc \u00f6rne\u011fi ile yap\u0131lan ya da kan numunesinden \u00e7al\u0131\u015f\u0131lan molek\u00fcler test sonucunun negatif olmas\u0131 gerekmektedir.<\/p>\n
4- \u0130yile\u015fmi\u015f bireylerin, mevcut yasal mevzuata uygun olarak kan ba\u011f\u0131\u015f\u00e7\u0131s\u0131 olabilmesi i\u00e7in gerekli \u015fartlar\u0131 ta\u015f\u0131yor olmas\u0131 gerekmektedir. <\/p>\n
Plazma ba\u011f\u0131\u015f\u0131 i\u00e7in al\u0131nacak miktar bir seferde 400 mililitreye kadar olabilecek. Bir ba\u011f\u0131\u015f\u00e7\u0131dan 400 mililitre plazma al\u0131nd\u0131ktan 1 hafta sonra, ikinci kez 400 mililitre daha ba\u011f\u0131\u015f al\u0131nabilecek. Yani bir ba\u011f\u0131\u015f\u00e7\u0131 2 sefer plazmas\u0131n\u0131 ba\u011f\u0131\u015flayarak iki hastaya destek verebilecek.<\/p>\n
Plazma ba\u011f\u0131\u015f\u0131 T\u00fcrk K\u0131z\u0131lay\u0131n \u0130stanbul’daki Kartal, Zeynep Kamil, \u00c7apa ve Ba\u015fak\u015fehir olmak \u00fczere 4 merkezinden al\u0131nabilecek. Ankara, \u0130zmir ve di\u011fer b\u00f6lgelerdeki detayl\u0131 adresler de vatanda\u015flara ula\u015ft\u0131r\u0131lacak.<\/p>\n
\u00d6te yandan bile\u015fenin izlenebilirli\u011fi amac\u0131yla imm\u00fcn plazma i\u00e7in T\u00fcrk K\u0131z\u0131lay\u0131ndan “ISBT 128” kodu
\nal\u0131nmas\u0131 gerekecek.<\/p>\n
Ayr\u0131ca imm\u00fcn plazma tedarik ve uygulamas\u0131nda Sosyal G\u00fcvenlik Kurumunun belirlemi\u015f oldu\u011fu \u00fccret d\u0131\u015f\u0131nda hi\u00e7bir ek \u00fccret al\u0131namayacak.<\/p>\n
1900’lerin ba\u015f\u0131ndan bu yana t\u0131p camias\u0131nda bilinen ve uygulanan bir y\u00f6ntem olan imm\u00fcn plazma tedavisi, ge\u00e7mi\u015fte d\u00fcnyay\u0131 etkisi alt\u0131na alan SARS, MERS, Ebola gibi salg\u0131nlarda da D\u00fcnya Sa\u011fl\u0131k \u00d6rg\u00fct\u00fc (DS\u00d6) taraf\u0131ndan uygulanmas\u0131 \u00f6nerilen bir y\u00f6ntem.<\/p>\n
DS\u00d6, Kovid-19 salg\u0131n\u0131na kar\u015f\u0131 kan mevzuat\u0131 i\u00e7in yay\u0131nlad\u0131\u011f\u0131 ara durum bildirgesiyle pandemi s\u0131ras\u0131nda imm\u00fcn plazma tedavisinin tavsiye edilen potansiyel tedavilerden biri oldug\u0306unu, yetkili otoritelerin imm\u00fcn plazma ya da serumun toplanmas\u0131 i\u00e7in uygun d\u00fczenleyici ko\u015fullar\u0131 olu\u015fturarak bu alanda ilerlemeleri gerekti\u011fini vurgulad\u0131.<\/p>\n\n","protected":false},"excerpt":{"rendered":"
Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131n\u0131n koordinasyonunda T\u00fcrk K\u0131z\u0131lay\u0131n\u0131n y\u00fcr\u00fct\u00fcc\u00fcl\u00fc\u011f\u00fcnde, k\u00fcresel bir sa\u011fl\u0131k sorunu haline gelen yeni tip koronavir\u00fcs (Kovid-19) tedavisinde kullan\u0131laca\u011f\u0131 duyurulan “imm\u00fcn plazma” tedavisi gelecek hafta devreye al\u0131nacak. \u0130lk olarak \u00c7in’in Vuhan kentinde ge\u00e7en y\u0131l aral\u0131k ay\u0131nda ortaya \u00e7\u0131kan, zamanla farkl\u0131 \u00fclke ve b\u00f6lgelere s\u0131\u00e7rayarak binlerce ki\u015fiye bula\u015fan koronavir\u00fcs salg\u0131n\u0131n\u0131 sona erdirmesi umut edilen ila\u00e7 ve a\u015f\u0131 …<\/p>\n","protected":false},"author":4,"featured_media":288709,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[763,5005,6669,349],"tags":[1253,220661,220589,29332,220418,220588],"class_list":["post-288708","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-gunun-olayi","category-manset","category-saglik","category-son-dakika","tag-dunya-saglik-orgutu","tag-gunun-olayi","tag-immun-plazma-tedavisi","tag-kizilay","tag-koronavirus","tag-plazma-tedavisi"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.nationalturk.com\/tr\/wp-json\/wp\/v2\/posts\/288708","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.nationalturk.com\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.nationalturk.com\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.nationalturk.com\/tr\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nationalturk.com\/tr\/wp-json\/wp\/v2\/comments?post=288708"}],"version-history":[{"count":0,"href":"https:\/\/www.nationalturk.com\/tr\/wp-json\/wp\/v2\/posts\/288708\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.nationalturk.com\/tr\/wp-json\/wp\/v2\/media\/288709"}],"wp:attachment":[{"href":"https:\/\/www.nationalturk.com\/tr\/wp-json\/wp\/v2\/media?parent=288708"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.nationalturk.com\/tr\/wp-json\/wp\/v2\/categories?post=288708"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.nationalturk.com\/tr\/wp-json\/wp\/v2\/tags?post=288708"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}